$31.99
0.341.07%
At close: Jan 9, 4:00 PM EST
$32.13
0.140.44%
After Hours: Jan 9, 7:58 PM EST
Comments
Loading...
Viking Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VKTX | Benzinga
Viking Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 4
EPS Estimate
$-0.890
Quarterly Revenue Estimate
$10.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Viking Therapeutics using advanced sorting and filters.
Viking Therapeutics (VKTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-22 | $-0.81 | $-0.68 | -19.1 % |
| Q2 | 2025-07-23 | $-0.58 | $-0.44 | -31.8 % |
| Q1 | 2025-04-23 | $-0.41 | $-0.31 | -32.3 % |
| Q4 | 2025-02-05 | $-0.32 | $-0.27 | -18.5 % |
Viking Therapeutics (VKTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?
Viking Therapeutics (VKTX) is scheduled to report earnings on February 4, 2026. The last reported earnings were for reported on October 22, 2025 for Q3.
What were the latest earnings per share (EPS) for Viking Therapeutics (NASDAQ:VKTX)?
The Actual EPS was $-0.81, which missed the estimate of $-0.68.
What were Viking Therapeutics’s (NASDAQ:VKTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
